Semipermanent and Permanent Injectable Fillers

Dermatologic Clinics

Volumn 27, Issue 4, 2009, Pages 433-444

  Jones, Derek H ^a  

^a Skin Care and Laser Physicians of Beverly Hills   (United States)

Author keywords

Calcium hyaluronic polylactic acid; Hyaluronic acid; Polymethyl methacrylate; Semipermanent and permanent fillers

Indexed keywords

COLLAGEN; FILLER; HYALURONIC ACID; HYDROXYAPATITE; POLY(METHYL METHACRYLATE); POLYLACTIC ACID;

CLINICAL EFFECTIVENESS; CLINICAL TRIAL; GRANULOMATOUS INFLAMMATION; HUMAN; HYDROGEL; KELOID; LIPOATROPHY; PATIENT SAFETY; PATIENT SATISFACTION; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; SURGICAL TECHNIQUE; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; WRINKLE;

BIOCOMPATIBLE MATERIALS; COSMETIC TECHNIQUES; HUMANS; HYALURONIC ACID; MICROSPHERES; POLYMETHYL METHACRYLATE; REJUVENATION;

EID: 70350026674     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2009.08.003     Document Type: Review

References (27)

1. Klein A., and Elson M. The history of substances for soft tissue augmentation. Dermatol Surg 26 (2000) 1096-1105
2. Coleman K.M., Voights R., DeVore D.P., et al. Neocollagenesis after injection of calcium hydroxylapatite composition in a canine model. Dermatol Surg 34 (2008) S53-S55
3. Berlin A.L., Hussain M., and Goldberg D.J. Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis. Dermatol Surg 34 (2008) S64-S67
4. Smith S., Busso M., McClaren M., et al. A randomized, bilateral, prospective comparison of calcium hydroxylapatite microspheres versus human-based collagen for the correction of nasolabial folds. Dermatol Surg 33 (2007) S112-S121
5. Busso M., and Voigts R. An investigation of changes in physical properties of injectable calcium hydroxylapatite in a carrier gel when mixed with lidocaine and with lidocaine/epinephrine. Dermatol Surg 34 (2008) S16-S23
6. Carruthers A., Liebeskind M., Carruthers J., et al. Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV-associated facial lipoatrophy and correction of nasolabial folds. Dermatol Surg 34 (2008) S78-S84
7. Carruthers A., and Carruthers J. Evaluation of injectable calcium hydroxylapatite for the treatment of facial lipoatrophy associated with human immunodeficiency virus. Dermatol Surg 34 (2008) 1486-1499
8. Silvers S.L., Eviatar J.A., Eschavez M.I., et al. Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one year durability. Plast Reconstr Surg 118 (2006) 34S-45S
9. Alam M., Gladstone H., Kramer E., et al. ASDS guidelines of care: injectable fillers. Dermatol Surg 34 (2008) S115-S148
10. Valantin M.A., Aubron-Olivier C., Ghosn J., et al. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS 17 (2003) 2471-2477
11. Sculptra®Aesthetic Product Information. Dermik Laboratories; 2009.
12. Wildemore J.K., and Jones D.H. Persistent granulomatous inflammatory response induced by injectable poly-L-lactic acid for HIV lipoatrophy. Dermatol Surg 32 (2006) 1407-1409
13. Jones D., and Vleggaar D. Technique for injecting poly-L-lactic acid. J Drugs Dermatol 6 (2007) S13-S17
14. Baumann L.S., Shamban A.T., Lupo M.P., et al. Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked randomized, within-subject study. Dermatol Surg 33 (2007) S128-S135
15. Narins R.S., Brandt F., Leyden J., et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 29 (2003) 588
16. Narins R.S., Davan S.H., Brandt F.S., et al. Persistence and improvement of nasolabial fold correction with nonanimal-stabilized hyaluronic acid 100,000 gel particles/mL filler on two treatment schedules: results up to 18 months on two retreatment schedules. Dermatol Surg 34 (2008) S2-S8
17. Smith S, Jones D. Efficacy and safety following repeat treatment for a new family of hyaluronic acid based fillers. In: Programs and abstracts of the 64th American Academy of Dermatology Annual Meeting. San Diego (CA), July 26-30, 2006.
18. Lupton J.R., and Alster T.S. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg 26 (2001) 135-137
19. Brody H.J. Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement. Dermatol Surg 31 8 Pt 1 (2005) 893-897
20. Jones D., Carruthers A., Orentreich D., et al. Highly Purified 1000-cST silicon oil for treatment of human immunodeficiency virus-associated facial lipoatrophy: an open pilot trial. Dermatol Surg 30 (2004) 1279-1286
21. Barnett J.G., and Barnett G.R. Treatment of acne scars with liquid silicone injections: 30-year perspective. Dermatol Surg 31 (2005) 1542-1549
22. Jones D. HIV facial lipoatrophy: causes and treatment options. Dermatol Surg 31 (2005) 1519-1529
23. Cohen S.R., and Holmes R.E. Artecoll: a long-lasting injectable wrinkle filler material: report of a controlled, randomized, multicenter clinical trial of 251 subjects. Plast Reconstr Surg 114 (2004) 964-976
24. Cohen S.R., Berner C.F., Busso M., et al. Artefill: a long-lasting injectable wrinkle filler material-summary of the U.S. Food and Drug Administration trials and a progress report on 4- to 5-year outcomes. Plast Reconstr Surg 118 35 (2006) 64S-76S
25. Protopapa C., Giuseppe S., Caporale D., et al. Bio-Alcamid in drug-induced lipodystrophy. J Cosmet Laser Ther 5 (2003) 226-230
26. Treacy P., and Goldberg D. Use of a biopolymer polyalkylimide filler for facial lipodystrophy in HIV-positive patients undergoing treatment with antiretroviral drugs. J Dermatol Surg 32 (2006) 804-808
27. Jones D.H., Carruthers A., Fitzgerald R., et al. Late-appearing abscesses after injections of nonabsorbable hydrogel polymer for HIV-associated facial lipoatrophy. Dermatol Surg 33 (2007) S193-S198